Combining Observational and Physiologic Sedation Assessment Tools (COST)

This study has been terminated.
(Lack of equipoise)
Sponsor:
Collaborators:
University of North Carolina
Covidien
Information provided by:
Duke University
ClinicalTrials.gov Identifier:
NCT00538369
First received: October 1, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted

October 1, 2007
October 1, 2007
November 2006
Not Provided
How much sedative was infused [ Time Frame: length of stay ]
Same as current
No Changes Posted
  • How quickly the subject recovered from sedation [ Time Frame: once ]
  • The number of undersedation events [ Time Frame: length of stay in ICU ]
Same as current
Not Provided
Not Provided
 
Combining Observational and Physiologic Sedation Assessment Tools
Combining Observational and Physiologic Sedation Assessment Tools

When a physiologic tool to measure the patient's hypnotic state is added to current practice tools is there a decrease in the amount of drug the patient receives.

The purposes of this study were to examine the effect of combining a physiologic measure of consciousness (BIS) with observational assessment of sedation (Ramsay) on infused sedation drug volumes, undersedation events, and the recovery time to arouse from sedation, in a group of neurocritically ill patients. During a 12-hour data collection period, patients received sedation assessment and management with either the current standard of care (sedation assessment with the Ramsay scale), or the standard of care plus the addition of physiologic data from BIS monitoring. Planned research questions explored how BIS monitoring impacts short-term sedation-related outcomes.

Research Questions

  • Is there less sedation drug use for patients when nurses monitor sedation with BIS augmentation of Ramsay than when nurses monitor patients with Ramsay alone?
  • Is sedation assessment augmented by BIS use associated with a decreased time to wake-up (recovery time) when nurses are instructed to interrupt sedation and obtain a neurologic examination, compared to use of Ramsay alone?
  • Are there differences in the number of events associated with undersedation (e.g., self-extubation) for patients assigned to BIS augmentation compared to patients assigned to Ramsay alone?
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Brain Injury
  • Other: Ramsay Scale
    While receiving sedation, subjects will be monitored with the Ramsay scale
    Other Name: Ramsay sedation scale
  • Device: Bispectral index monitor
    While receiving sedation, subjects will receive BIS monitoring
    Other Name: BIS
  • Active Comparator: standard-of-care
    The standard-of-care group will receive sedation assessment and monitoring with the Ramsay scale, which is the accepted tool at this university
    Intervention: Other: Ramsay Scale
  • Experimental: standard + BIS
    Subjects in the standard-of-care + BIS group will receive sedation assessment and monitoring using the Ramsay scale and values from the bispectral index (BIS) monitor.
    Interventions:
    • Other: Ramsay Scale
    • Device: Bispectral index monitor
Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974 Jun 22;2(5920):656-9. No abstract available.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
67
September 2007
Not Provided

Inclusion Criteria:

  • Adult
  • admitted with a neurological or neurosurgical diagnosis
  • intubated and on mechanical ventilatory support
  • receiving continuous sedation with propofol
  • Glasgow Coma Score <12

Exclusion Criteria:

  • bifrontal brain injury
  • status epilepticus
  • barbiturate coma therapy
  • continuous benzodiazepine administration
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00538369
8771, 8771-06 - 8RO
Yes
Not Provided
Duke University
  • University of North Carolina
  • Covidien
Principal Investigator: DaiWai M Olson, PhD RN CCRN Duke University
Study Chair: Suzanne M Thoyre, PhD RN University of North Carolina, Chapel Hill
Study Director: Carmelo Graffagnino, MD FRCPC Duke University
Duke University
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP